Dudediligence.

BioRestorative Therapies, Inc

BRTXNASDAQ · Services-Misc Health & Allied Services, NEC
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

25.5M

on 2026-03-31, from 6.77M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$1.0M

Rodman & Renshaw, agreement of 2025-10-06. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

4.50M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

1.2 quarters

$3.6M on 2026-03-31 ÷ $3.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-02-13Public offeringnot read$0.35$5.0M424B4 ↗
2025-10-06Public offering678,125$1.84$1.1M424B5 ↗
2025-10-06Registered direct offering678,125$1.60$1.1M8-K ↗

Also on file: up to $1.0M promissory note agreed 2026-06-10 8-K ↗ · a 1-for-20 reverse split, 2026-09-02 8-K ↗